Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction

We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hyd...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of pediatrics 1991-07, Vol.150 (9), p.665-668
Hauptverfasser: WALKA, M. M, DAUMLING, S, HADORN, H.-B, KRUSE, K, BELOHRADSKY, B. H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 668
container_issue 9
container_start_page 665
container_title European journal of pediatrics
container_volume 150
creator WALKA, M. M
DAUMLING, S
HADORN, H.-B
KRUSE, K
BELOHRADSKY, B. H
description We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.
doi_str_mv 10.1007/BF02072630
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72123147</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72123147</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</originalsourceid><addsrcrecordid>eNpFkEtLxDAURoMo4zi6cS9kIS6E6k2aNOlSR0cHRtyo25LmgdE2rU2L9N9bmUFXd_EdDpeD0CmBKwIgrm9XQEHQLIU9NCcspQkBke2jOaQMkozk-SE6ivEDJjgncoZmJOOcZXSOnt58r2of8B02trXB2NDjzutP20fcj63F6zX-9v07rkdbNc6XXRN9xCoY7Ot6CBabMboh6N434RgdOFVFe7K7C_S6un9ZPiab54f18maT6JSQPqECBBDLwIJjCoARQWXpXEYZpSWlhBrDcihlKjPKpTHCMW4lByUzaTRNF-hi62275muwsS9qH7WtKhVsM8RCTIqUMDGBl1tQT2_Hzrqi7XyturEgUPy2K_7bTfDZzjqUtTX_6DbWtJ_vdhW1qlyngvbxD-OUcU4g_QEWfHQX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72123147</pqid></control><display><type>article</type><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</creator><creatorcontrib>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</creatorcontrib><description>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</description><identifier>ISSN: 0340-6199</identifier><identifier>EISSN: 1432-1076</identifier><identifier>DOI: 10.1007/BF02072630</identifier><identifier>PMID: 1655462</identifier><identifier>CODEN: EJPEDT</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Biological and medical sciences ; Calcium - therapeutic use ; Chemotaxis, Leukocyte ; Diseases of the osteoarticular system ; Humans ; Hypophosphatemia, Familial - complications ; Hypophosphatemia, Familial - drug therapy ; Hypophosphatemia, Familial - immunology ; Immunoglobulin G - analysis ; Immunoglobulin M - analysis ; Infant ; Infusions, Intravenous ; Male ; Malformations and congenital and or hereditary diseases involving bones. Joint deformations ; Medical sciences ; Neutrophils - physiology ; Primary Myelofibrosis - complications</subject><ispartof>European journal of pediatrics, 1991-07, Vol.150 (9), p.665-668</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</citedby><cites>FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5245510$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1655462$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WALKA, M. M</creatorcontrib><creatorcontrib>DAUMLING, S</creatorcontrib><creatorcontrib>HADORN, H.-B</creatorcontrib><creatorcontrib>KRUSE, K</creatorcontrib><creatorcontrib>BELOHRADSKY, B. H</creatorcontrib><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><title>European journal of pediatrics</title><addtitle>Eur J Pediatr</addtitle><description>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</description><subject>Biological and medical sciences</subject><subject>Calcium - therapeutic use</subject><subject>Chemotaxis, Leukocyte</subject><subject>Diseases of the osteoarticular system</subject><subject>Humans</subject><subject>Hypophosphatemia, Familial - complications</subject><subject>Hypophosphatemia, Familial - drug therapy</subject><subject>Hypophosphatemia, Familial - immunology</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin M - analysis</subject><subject>Infant</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Malformations and congenital and or hereditary diseases involving bones. Joint deformations</subject><subject>Medical sciences</subject><subject>Neutrophils - physiology</subject><subject>Primary Myelofibrosis - complications</subject><issn>0340-6199</issn><issn>1432-1076</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLxDAURoMo4zi6cS9kIS6E6k2aNOlSR0cHRtyo25LmgdE2rU2L9N9bmUFXd_EdDpeD0CmBKwIgrm9XQEHQLIU9NCcspQkBke2jOaQMkozk-SE6ivEDJjgncoZmJOOcZXSOnt58r2of8B02trXB2NDjzutP20fcj63F6zX-9v07rkdbNc6XXRN9xCoY7Ot6CBabMboh6N434RgdOFVFe7K7C_S6un9ZPiab54f18maT6JSQPqECBBDLwIJjCoARQWXpXEYZpSWlhBrDcihlKjPKpTHCMW4lByUzaTRNF-hi62275muwsS9qH7WtKhVsM8RCTIqUMDGBl1tQT2_Hzrqi7XyturEgUPy2K_7bTfDZzjqUtTX_6DbWtJ_vdhW1qlyngvbxD-OUcU4g_QEWfHQX</recordid><startdate>19910701</startdate><enddate>19910701</enddate><creator>WALKA, M. M</creator><creator>DAUMLING, S</creator><creator>HADORN, H.-B</creator><creator>KRUSE, K</creator><creator>BELOHRADSKY, B. H</creator><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19910701</creationdate><title>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</title><author>WALKA, M. M ; DAUMLING, S ; HADORN, H.-B ; KRUSE, K ; BELOHRADSKY, B. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-270701e40e0f4a0041728bff62422b2212dd490b8386258dd7f45e850a868dc23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Biological and medical sciences</topic><topic>Calcium - therapeutic use</topic><topic>Chemotaxis, Leukocyte</topic><topic>Diseases of the osteoarticular system</topic><topic>Humans</topic><topic>Hypophosphatemia, Familial - complications</topic><topic>Hypophosphatemia, Familial - drug therapy</topic><topic>Hypophosphatemia, Familial - immunology</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin M - analysis</topic><topic>Infant</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Malformations and congenital and or hereditary diseases involving bones. Joint deformations</topic><topic>Medical sciences</topic><topic>Neutrophils - physiology</topic><topic>Primary Myelofibrosis - complications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WALKA, M. M</creatorcontrib><creatorcontrib>DAUMLING, S</creatorcontrib><creatorcontrib>HADORN, H.-B</creatorcontrib><creatorcontrib>KRUSE, K</creatorcontrib><creatorcontrib>BELOHRADSKY, B. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WALKA, M. M</au><au>DAUMLING, S</au><au>HADORN, H.-B</au><au>KRUSE, K</au><au>BELOHRADSKY, B. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction</atitle><jtitle>European journal of pediatrics</jtitle><addtitle>Eur J Pediatr</addtitle><date>1991-07-01</date><risdate>1991</risdate><volume>150</volume><issue>9</issue><spage>665</spage><epage>668</epage><pages>665-668</pages><issn>0340-6199</issn><eissn>1432-1076</eissn><coden>EJPEDT</coden><abstract>We present a new patient with vitamin D dependent rickets type II. A 20-month-old Arabian boy whose parents are first cousins showed florid rickets, myelofibrosis and recurrent septicaemia. In addition to absent specific binding for 1,25-dihydroxyvitamin D3 (1,25(OH)2D3). 25-Hydroxyvitamin D3-24-hydroxylase activity could not be induced in cultured fibroblasts. The patient did not respond to 99 micrograms 1,25(OH)2D3 per day, but skeletal and haematological abnormalities improved with daily infusion of 100 mg/kg calcium, as serum parathyroid hormone levels fell to normal values. At the age of 7 years, he died from pneumonia. The improvement of haematological abnormalities with calcium infusions but not with 1.25(OH)2D3 suggests a pathogenetic relationship of myelofibrosis and hyperparathyroidism. Having anti-lipid A IgM antibody titres up to 1:10.000 after Gram negative septicaemias, the patient never produced corresponding IgG antibodies. His neutrophil chemotaxis was persistently reduced to 57% +/- 3% of age-matched controls (P less than 0.028). The patient showed two pathological immune functions considered to contribute to the well-known susceptibility to infection in rickets.</abstract><cop>Heidelberg</cop><cop>Berlin</cop><pub>Springer</pub><pmid>1655462</pmid><doi>10.1007/BF02072630</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0340-6199
ispartof European journal of pediatrics, 1991-07, Vol.150 (9), p.665-668
issn 0340-6199
1432-1076
language eng
recordid cdi_proquest_miscellaneous_72123147
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Biological and medical sciences
Calcium - therapeutic use
Chemotaxis, Leukocyte
Diseases of the osteoarticular system
Humans
Hypophosphatemia, Familial - complications
Hypophosphatemia, Familial - drug therapy
Hypophosphatemia, Familial - immunology
Immunoglobulin G - analysis
Immunoglobulin M - analysis
Infant
Infusions, Intravenous
Male
Malformations and congenital and or hereditary diseases involving bones. Joint deformations
Medical sciences
Neutrophils - physiology
Primary Myelofibrosis - complications
title Vitamin D dependent rickets type II with myelofibrosis and immune dysfunction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A04%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Vitamin%20D%20dependent%20rickets%20type%20II%20with%20myelofibrosis%20and%20immune%20dysfunction&rft.jtitle=European%20journal%20of%20pediatrics&rft.au=WALKA,%20M.%20M&rft.date=1991-07-01&rft.volume=150&rft.issue=9&rft.spage=665&rft.epage=668&rft.pages=665-668&rft.issn=0340-6199&rft.eissn=1432-1076&rft.coden=EJPEDT&rft_id=info:doi/10.1007/BF02072630&rft_dat=%3Cproquest_cross%3E72123147%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72123147&rft_id=info:pmid/1655462&rfr_iscdi=true